Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells-Reference-Cited by-同舟云学术

Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells

Published:2013-06 Issue:5 Volume:24 Page:473-483
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Kawahara Satomi,Otsuji Yoko,Nakamura Mitsuhiro,Murakami Masashi,Murate Takashi,Matsunaga Toshiyuki,Kanoh Hiroyuki,Seishima Mariko,Banno Yoshiko,Hara Akira

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference41 articles.

1. Ceramide in apoptosis: an overview and current perspectives.;Pettus;Biochim Biophys Acta,2002

2. Sphingosine-1-phosphate: an enigmatic signalling lipid.;Spiegel;Nat Rev Mol Cell Biol,2003

3. Biologically active sphingolipids in cancer pathogenesis and treatment.;Ogretmen;Nat Rev Cancer,2004

4. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases.;Hait;Biochim Biophys Acta,2006

5. Alterations of ceramidesphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells.;Baran;J Biol Chem,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered Lipidic Nanomaterials Inspired by Sphingomyelin Metabolism for Cancer Therapy;Molecules;2023-07-12

2. Integration of metabolites from meta-analysis with transcriptome reveals enhanced SPHK1 in PDAC with a background of pancreatitis;BMC Cancer;2022-07-19

3. S1P signaling, its interactions and cross-talks with other partners and therapeutic importance in colorectal cancer;Cellular Signalling;2021-10

4. Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer;Pharmaceuticals;2021-06-18

5. Increased SPHK1 and HAS2 Expressions Correlate to Poor Prognosis in Pancreatic Cancer;BioMed Research International;2021-01-06